Adamas Pharmaceuticals
ADMS
#8057
Rank
โ‚ฌ0.33 B
Marketcap
7,42ย โ‚ฌ
Share price
0.00%
Change (1 day)
17,094.37%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): โ‚ฌ74.45 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is โ‚ฌ79.59 Million. In 2020 the company made a revenue of โ‚ฌ67.2 Million an increase over the revenue in the year 2019 that were of โ‚ฌ49.31 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ74.45 M10.78%
2020โ‚ฌ67.2 M36.28%
2019โ‚ฌ49.31 M60.48%
2018โ‚ฌ30.72 M
2016โ‚ฌ0.51 M-70.15%
2015โ‚ฌ1.72 M-96.57%
2014โ‚ฌ50.4 M-21.45%
2013โ‚ฌ64.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AbbVie
ABBV
โ‚ฌ59.58 B 74,755.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ60.81 B 76,301.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ40.29 B 50,518.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
โ‚ฌ73.73 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Supernus Pharmaceuticals
SUPN
โ‚ฌ0.78 B 880.97%๐Ÿ‡บ๐Ÿ‡ธ USA